RAIADROGASILON NMRR

RAIADROGASILON NM

19.61BRLD
−0.24−1.21%
At close at Feb 17, 21:05 GMT
BRL
No trades
See on Supercharts

RADL3F fundamentals

Key facts

Market capitalization‪34.26 B‬BRL
Founded1905
Employees (FY)‪57.69 K‬
CEORenato Raduan
About

Raia Drogasil SA engages in the retail sale of medicine, perfumery, personal care and beauty products, cosmetics and dermocosmetics. Its stores are supplied by distribution centers located in the states of São Paulo, Rio de Janeiro, Minas Gerais, Paraná, Goiás, Pernambuco, and Bahia. The company was founded in 1905 and is headquartered in Butanta, Brazil.

Ownership
‪‪1.72 B‬‬
Free Float shares
‪‪1.27 B‬‬ (74.14%)
Closely held shares
‪‪443.53 M‬‬ (25.86%)
Free Float shares
‪‪1.27 B‬‬ (74.14%)
Closely held shares
‪‪443.53 M‬‬ (25.86%)
Capital structure
Market cap
‪‪34.26 B‬‬
Debt
‪‪7.57 B‬‬
Minority interest
‪‪13.47 M‬‬
Cash & equivalents
‪‪410.51 M‬‬
Enterprise value
‪‪41.44 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪34.26 B‬‬
Price to earning ratio (P/E)
30.51x
Price to sales ratio (P/S)
0.90x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
30.51x
Price to sales ratio (P/S)
0.90x
Valuation ratios
‪0.00‬
‪0.40‬
‪0.80‬
‪1.20‬
‪1.60‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪12.00‬
‪24.00‬
‪36.00‬
‪48.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪2.0%‬
‪2.4%‬
‪2.8%‬
‪3.2%‬
‪3.6%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪2.50 B‬‬
‪‪5.00 B‬‬
‪‪7.50 B‬‬
‪‪10.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪2.50 B‬‬
‪‪5.00 B‬‬
‪‪7.50 B‬‬
‪‪10.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪2.50 B‬‬
‪‪5.00 B‬‬
‪‪7.50 B‬‬
‪‪10.00 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Medicines, Perfumery, Personal Care and Beauty Products, Cosmetics and Dermocosmetics and Specialty Medicines
Service
By country
Period: 2023
Brazil

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪3.00 B‬‬
‪‪6.00 B‬‬
‪‪9.00 B‬‬
‪‪12.00 B‬‬
Actual
Estimate
Earnings
Next:Feb 25, 2025
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪0.06‬
‪0.12‬
‪0.18‬
‪0.24‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
48.46%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
1.44%
Last payment
0.072
Last ex-date
Dec 5, 2024
Dividend history
‪0.55%‬
‪0.75%‬
‪0.95%‬
‪1.15%‬
‪1.35%‬
2019
2020
2021
2022
2023
‪0.00‬
‪0.08‬
‪0.16‬
‪0.24‬
‪0.32‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−2.60 B‬‬
‪0.00‬
‪‪2.60 B‬‬
‪‪5.20 B‬‬
‪‪7.80 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪3.50 B‬‬
‪‪7.00 B‬‬
‪‪10.50 B‬‬
‪‪14.00 B‬‬
Assets
Liabilities